Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2003
10/08/2003EP1100530B1 In-vitro stimulation of beta cell proliferation
10/08/2003EP1074556B1 Phosphonic acid diester derivatives
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0882707B1 Novel tricyclic compounds and drug compositions containing the same
10/08/2003EP0818956B1 Cereal food product high in soluble fiber
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447850A Purifying crude pufa oils
10/08/2003CN1447807A Chromenone derivatives and their use for treating diseases in conjunction with 5-HT1A receptors and/or dopamine D2 receptors
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447788A Process for prodn. of calcium pantothenate
10/08/2003CN1446813A Novel dihydric indole compound, their prepn. process and medicinal compsns. contg.them
10/08/2003CN1446790A Medicinal grade ferrum citricum iron-59 citrate and its preparation method
10/08/2003CN1446580A Preparation of effective component from rhodiola crenulate
10/08/2003CN1446566A ÔÇÿTangxiaokangÔÇÖ capsule
10/08/2003CN1446546A Biology calcium health foods made from sierra fish bone and its preparation method
10/08/2003CN1123358C Oral liquid for treating cerebrovascular disease
10/08/2003CN1123350C Medicine for treating oyeground affection of diabetes
10/08/2003CN1123347C Chinese medicine for decreasing fat and losing weight and prepn. method thereof
10/08/2003CN1123346C Animal cartilage health-care capsule for inhibiting tumour growth, eliminating free radical and anti peroxidation of lipid and prepn. method thereof
10/08/2003CN1123342C Use of inhibitors of renin-angiotension system
10/08/2003CN1123339C Diabetes remedies
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630509 Phenalkyloxy-phenyl derivatives
10/07/2003US6630506 Useful as antianginal agents, and cardioprotective agents and for treating peripheral vascular disease including intermittent claudication
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630502 Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630487 Treatment of insulin resistance with growth hormone secretagogues
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630467 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
10/07/2003US6630453 Androgen derivatives and uses thereof
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630178 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
10/07/2003US6630157 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2291620C Production method of isoxazolidinedione compound
10/07/2003CA2094808C Oxysulfonyl urea acat inhibitors
10/07/2003CA2091602C Highly concentrated amino acid solution
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080635A1 Crystals of glucopyranosyloxybenzyl benzene derivative
10/02/2003WO2003080634A1 Novel glucopyranoside and a process of isolation thereof from pterocarpus marsupium pharmaceutical composition containing the same and use thereof
10/02/2003WO2003080633A1 Novel $g(a)-amino-n-(diaminophosphinyl)lactam derivative
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080608A2 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080605A1 Thiazolidinedione derivatives and pharmaceutical composition comprising the same
10/02/2003WO2003080585A1 Novel aminobenzamide derivative
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080580A2 Quinoline derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003WO2003080125A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080087A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation
10/02/2003WO2003080084A1 A process for the extraction of anthocyanins from black rice and composition thereof
10/02/2003WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor
10/02/2003WO2003080070A2 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003WO2003080069A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003WO2003080068A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080063A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080056A2 Fine particle size pioglitazone
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080038A1 Preventive or therapeutic agent for kidney disease
10/02/2003WO2003079998A2 Treatment of diseases involving defective gap junctional communication
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079885A2 Inhalable sustained therapeutic formulations
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003061638A3 Use of phosphodiesterase antagonists to treat insulin resistance
10/02/2003WO2003057862A3 Transdifferentiation of pancreatic acinar cells
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003033534A3 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
10/02/2003WO2003020206A3 Use of atazanavir in hiv therapy
10/02/2003WO2003011906A3 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2003006604A3 Cyclic peptides as potent and selective melanocortin-4 receptor agonists
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003WO2002032408A3 Combinations of a thyromimetic compound and a statin
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187254 Anticholesterol agents; cardiovascular disorders; dietetics; antidiabetic agents
10/02/2003US20030187058 Synergistic mixture of lipoic acid and another fatty acid; antidiabetic agents
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187047 Vision defects; non-insulin diabetic agents; impotency; dietetics
10/02/2003US20030187042 Modulate gene expression; antitumor agents; cardiovascular disorders; anticholesterol agents; antilipemic agents
1 ... 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 ... 1298